These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 25227521)

  • 1. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
    Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
    Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High quality of screening colonoscopy in Austria is not dependent on endoscopist specialty or setting.
    Kozbial K; Reinhart K; Heinze G; Zwatz C; Bannert C; Salzl P; Waldmann E; Britto-Arias M; Ferlitsch A; Trauner M; Weiss W; Ferlitsch M
    Endoscopy; 2015 Mar; 47(3):207-16. PubMed ID: 25412094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for colorectal cancer in Italy, 2010 survey].
    Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sedation in screening colonoscopy: impact on quality indicators and complications.
    Bannert C; Reinhart K; Dunkler D; Trauner M; Renner F; Knoflach P; Ferlitsch A; Weiss W; Ferlitsch M
    Am J Gastroenterol; 2012 Dec; 107(12):1837-48. PubMed ID: 23147522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations between endoscopists in rates of detection of colorectal neoplasia and their impact on a regional screening program based on colonoscopy after fecal occult blood testing.
    Bretagne JF; Hamonic S; Piette C; Manfredi S; Leray E; Durand G; Riou F
    Gastrointest Endosc; 2010 Feb; 71(2):335-41. PubMed ID: 19922930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for colorectal cancer in Italy: 2005 survey.
    Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of endoscopic surveillance recommendations in organised colorectal cancer screening programmes based on the faecal immunochemical test.
    Zorzi M; Senore C; Turrin A; Mantellini P; Visioli CB; Naldoni C; Sassoli De' Bianchi P; Fedato C; Anghinoni E; Zappa M; Hassan C;
    Gut; 2016 Nov; 65(11):1822-1828. PubMed ID: 26297727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study.
    Denis B; Sauleau EA; Gendre I; Exbrayat C; Piette C; Dancourt V; Foll Y; Ait Hadad H; Bailly L; Perrin P
    Dig Liver Dis; 2014 Feb; 46(2):176-81. PubMed ID: 24054769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies.
    Jover R; Zapater P; Polanía E; Bujanda L; Lanas A; Hermo JA; Cubiella J; Ono A; González-Méndez Y; Peris A; Pellisé M; Seoane A; Herreros-de-Tejada A; Ponce M; Marín-Gabriel JC; Chaparro M; Cacho G; Fernández-Díez S; Arenas J; Sopeña F; de-Castro L; Vega-Villaamil P; Rodríguez-Soler M; Carballo F; Salas D; Morillas JD; Andreu M; Quintero E; Castells A;
    Gastrointest Endosc; 2013 Mar; 77(3):381-389.e1. PubMed ID: 23218945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of adenoma detection and discrimination during colonoscopy in routine practice: an exploratory study.
    Denis B; Sauleau EA; Gendre I; Piette C; Bretagne JF; Perrin P
    Gastrointest Endosc; 2011 Dec; 74(6):1325-36. PubMed ID: 21958899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test.
    Binefa G; García M; Milà N; Rodríguez L; Rodríguez-Moranta F; Guardiola J; Moreno V
    Rev Esp Enferm Dig; 2013 Aug; 105(7):400-8. PubMed ID: 24206550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
    Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
    Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume and accreditation, but not specialty, affect quality standards in colonoscopy.
    Bhangu A; Bowley DM; Horner R; Baranowski E; Raman S; Karandikar S
    Br J Surg; 2012 Oct; 99(10):1436-44. PubMed ID: 22961527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a quarterly report card on colonoscopy quality measures.
    Kahi CJ; Ballard D; Shah AS; Mears R; Johnson CS
    Gastrointest Endosc; 2013 Jun; 77(6):925-31. PubMed ID: 23472996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
    Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
    Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
    Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
    Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.